DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Target Gene/Pathway
Pathway
/
Gene
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
entries per page:
Showing 1 to 10 of 81 entries
Filter by
Reset
No.
KEGG GENES
KEGG PATHWAY
KEGG DRUG
DrugBank
Disease ID
1
CYP11A1
[5]
Steroid hormone biosynthesis
Steroid hormone biosynthesis
,
Metabolic pathways
,
Ovarian steroidogenesis
,
Cortisol synthesis and secretion
,
Cushing syndrome
[5]
Steroid hormone biosynthesis
,
Metabolic pathways
,
Ovarian steroidogenesis
,
Cortisol synthesis an
...
D10950
D10950
Levoketoconazole
[1]
75
75
2
CYP11B1
[4]
Steroid hormone biosynthesis
Steroid hormone biosynthesis
,
Metabolic pathways
,
Cortisol synthesis and secretion
,
Cushing syndrome
[4]
Steroid hormone biosynthesis
,
Metabolic pathways
,
Cortisol synthesis and secretion
,
Cushing synd
...
D00410
D00410
Metyrapone
[1]
75
75
3
CYP11B1
[4]
Steroid hormone biosynthesis
Steroid hormone biosynthesis
,
Metabolic pathways
,
Cortisol synthesis and secretion
,
Cushing syndrome
[4]
Steroid hormone biosynthesis
,
Metabolic pathways
,
Cortisol synthesis and secretion
,
Cushing synd
...
D10950
D10950
Levoketoconazole
[1]
75
75
4
CYP17A1
[6]
Steroid hormone biosynthesis
Steroid hormone biosynthesis
,
Metabolic pathways
,
Ovarian steroidogenesis
,
Prolactin signaling pathway
,
Cortisol synthesis and secretion
,
Cushing syndrome
[6]
Steroid hormone biosynthesis
,
Metabolic pathways
,
Ovarian steroidogenesis
,
Prolactin signaling p
...
D00351
D00351
Ketoconazole
[3]
8
8
,
13
,
75
5
CYP17A1
[6]
Steroid hormone biosynthesis
Steroid hormone biosynthesis
,
Metabolic pathways
,
Ovarian steroidogenesis
,
Prolactin signaling pathway
,
Cortisol synthesis and secretion
,
Cushing syndrome
[6]
Steroid hormone biosynthesis
,
Metabolic pathways
,
Ovarian steroidogenesis
,
Prolactin signaling p
...
D10950
D10950
Levoketoconazole
[1]
75
75
6
AGTR1
[9]
Phospholipase D signaling pathway
Phospholipase D signaling pathway
,
Neuroactive ligand-receptor interaction
,
Vascular smooth muscle contraction
,
Renin-angiotensin system
,
Renin secretion
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Pathways in cancer
,
Diabetic cardiomyopathy
[9]
Phospholipase D signaling pathway
,
Neuroactive ligand-receptor interaction
,
Vascular smooth musc
...
D00150
D00150
Angiotensin II
[7]
17
17
,
19
,
46
,
66
,
86
,
222
,
224
7
AGTR1
[9]
Phospholipase D signaling pathway
Phospholipase D signaling pathway
,
Neuroactive ligand-receptor interaction
,
Vascular smooth muscle contraction
,
Renin-angiotensin system
,
Renin secretion
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Pathways in cancer
,
Diabetic cardiomyopathy
[9]
Phospholipase D signaling pathway
,
Neuroactive ligand-receptor interaction
,
Vascular smooth musc
...
D00400
D00400
Valsartan
[7]
57
57
,
58
,
66
,
75
,
218
,
222
,
224
8
AGTR1
[9]
Phospholipase D signaling pathway
Phospholipase D signaling pathway
,
Neuroactive ligand-receptor interaction
,
Vascular smooth muscle contraction
,
Renin-angiotensin system
,
Renin secretion
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Pathways in cancer
,
Diabetic cardiomyopathy
[9]
Phospholipase D signaling pathway
,
Neuroactive ligand-receptor interaction
,
Vascular smooth musc
...
D00522
D00522
Candesartan
[2]
58
58
,
67
9
AGTR1
[9]
Phospholipase D signaling pathway
Phospholipase D signaling pathway
,
Neuroactive ligand-receptor interaction
,
Vascular smooth muscle contraction
,
Renin-angiotensin system
,
Renin secretion
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Pathways in cancer
,
Diabetic cardiomyopathy
[9]
Phospholipase D signaling pathway
,
Neuroactive ligand-receptor interaction
,
Vascular smooth musc
...
D00523
D00523
Irbesartan
[4]
66
66
,
167
,
168
,
222
10
AGTR1
[9]
Phospholipase D signaling pathway
Phospholipase D signaling pathway
,
Neuroactive ligand-receptor interaction
,
Vascular smooth muscle contraction
,
Renin-angiotensin system
,
Renin secretion
,
Cortisol synthesis and secretion
,
Cushing syndrome
,
Pathways in cancer
,
Diabetic cardiomyopathy
[9]
Phospholipase D signaling pathway
,
Neuroactive ligand-receptor interaction
,
Vascular smooth musc
...
D00626
D00626
Candesartan cilexetil
[1]
67
67